Prevalence of colonization by group B Streptococcus in pregnant women from a public maternity of Northwest region of Brazil;Prevalência de colonização por estreptococos do grupo B em gestantes atendidas em maternidade pública da região Nordeste do Brasil

Revista Brasileira de Ginecologia e Obstetricia

Volumn 30, Issue 6, 2008, Pages 274-280

  Costa, Adriana Lima Dos Reis ^a,b,e   Lamy Filho, Fernando ^a,b   Chein, Maria Bethânia Da Costa ^a,b   Brito, Luciane Maria Oliveira ^a,b,c   Lamy, Zeni Carvalho ^a,b   Andrade, Kátia Lima ^a,d  

^a Maternidade Marly Sarney   (Brazil)

^b FEDERAL UNIVERSITY OF MARANHÃO   (Brazil)

^c Departamento de Medicina III

^d CEUMA UNIVERSITY   (Brazil)

^e Edifício Demoiselle Renascença II ^*  (United States)

Author keywords

Pregnancy; Pregnancy complications, infectious diagnosis; Prevalence; Streptococcus agalactiae isolation purification

Indexed keywords

EID: 51949107293     PISSN: 01007203     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0100-72032008000600002     Document Type: Article

References (36)

1. McCord N, Owen P, Powls A, Lunan B. A complete audit cycle of intrapartum group B streptococcus prophylaxis. Health Bull (Edinb). 2001;59(4):263-7.
2. Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep. 2002;51(RR-11):1-22.
3. Platt JS, O'Brien WF. Group B streptococcus: prevention of early-onset neonatal sepsis. Obstet Gynecol Surv. 2003;58(3):191-6.
4. Larsen JW, Sever JL. Group B streptococcus and pregnancy: a review. Am J Obstet Gynecol. 2008;198(4):440-8.
5. Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR Recomm Rep. 1996;45(RR-7):1-24. Erratum in: MMWR Morb Mortal Wkly Rep. 1996;45(31):679.
6. American College of Nurse-Midwives Early-onset group B infection in newborns: prevention and prophylaxis Number 2, April 2003 (replaces Clinical Bulletin number 2, January 1997). J Midwifery Womens Health. 2003;48(5):375-81.
7. Scharg SJ, Zell ER, Lynfield R, Roome A, Arnold KE, Craig AS, et al. A population-based compararison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med. 2002;347(4):233-9.
8. Centers for Disease Control and Prevention (CDC). Early-onset and late-onset neonatal group B streptococcal disease - United States, 1996-2004. MMWR Morb Mortal Wkly Rep. 2005;54(47):1205-8.
9. Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, Petit S, et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA. 2008;299(17):2056-65.
10. Amaral E. Estreptococo do grupo B: rastrear ou não rastrear no Brasil? Eis a questão. Rev Bras Ginecol Obstet. 2005;27(4):165-7.
11. Agência Nacional de Vigilância Sanitária (ANVISA). Manual de microbiologia clínica para o controle de infecções em serviços de saúde. Módulo 4: descrição dos meios de cultura empregados nos exames microbiológicos. Brasília; 2004.
12. National Committee for Clinical Laboratory Standards (NCCLS). Padronização dos testes de sensibilidade a antimicrobianos por disco-difusão: norma aprovada. 8a ed. Brasília: ANVISA; 2003.
13. Jauréguy F, Carton M, Teboul J, Butel MJ, Panel P, Ghnassia JC, et al. Risk factors and screening strategy for group B streptococcal colonization in pregnant women: results of a prospective study. J Gynecol Obstet Biol Reprod (Paris). 2003;32(2):132-8.
14. Benchetrit LC, Fracalanzza SE, Peregrino H, Camelo AA, Sanches LA. Carriage of Streptococcus agalactiae in women and neonates and distribution of serological types: a study in Brazil. J Clin Microbiol. 1982;15(5):787-90.
15. Smânia-Júnior A, Benchetrit LC, Smânia EFA, Fracalanzza SEL. Isolamento do estreptococos do grupo B de gestantes e neonatos em Florianópolis, Santa Catarina. Rev Bras Anal Clin. 1986;18(4):103-8.
16. Mocelin CO, Carvalho DAF, Brites C, Christofolli D, Mocelin AO, Fracalanzza SEL, et al. Isolamento do Streptococcus agalactiae de gestantes na região de Londrina-PR. Rev Bras Ginecol Obstet. 1995;17(9):915-8.
17. Beraldo C, Brito ASJ, Saridakis HO, Matsuo T. Prevalência da colonização vaginal e anorretal por estreptococo do grupo B em gestantes do terceiro trimestre. Rev Bras Ginecol Obstet. 2004;26(7):543-9.
18. Pogere A, Zoccoli CM, Tobouti NR, Freitas PF, d'Acampora J, Zunino JN. Prevalência da colonização pelo estreptococo do grupo B em gestantes atendidas no ambulatório de pré-natal. Rev Bras Ginecol Obstet. 2005;27(4):174-80.
19. Strickland DM, Yeomans ER, Hankins GD. Cost-effectiveness of intrapartum screening and treatment for maternal group B streptococci colonization. Am J Obstet Gynecol. 1990;163(1 Pt 1):4-8.
20. Centers for Disease Control and Prevention (CDC). Laboratory practices for prenatal group B streptococcal screening-seven states, 2003. MMRW Morb Mortal Wkly Rep. 2004;53(23):506-9.
21. Nomura ML, Passini Júnior R, Oliveira UM. Group B streptococcus colonization in preterm labor and preterm premature rupture of membranes. Int J Gynaecol Obstet. 2005;91(1):69-70.
22. Regan JA, Klebanoff MA, Nugent RP. The epidemiology of group B streptococcal colonization in pregnancy. Vaginal Infections and Prematurity Study Group. Obstet Gynecol. 1991;77(4):604-10.
23. Schuchat A. Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin Microbiol Rev. 1998;11(3):497-513.
24. Luck S, Torny M, d'Agapeyeff K, Pitt A, Heath P, Breathnach A, et al. Estimated early-onset group B streptococcal neonatal disease. Lancet. 2003;361(9373):1953-4.
25. Neto MT. Group B streptococcal disease in Portuguese infants younger than 90 days. Arch Dis Child Fetal Neonatal Ed. 2008;93(2):F90-3.
26. Miura E, Martin MC. Group B streptococcal neonatal infections in Rio Grande do Sul, Brazil. Rev Inst Med Trop São Paulo. 2001;43(5):243-6.
27. Pinheiro RS, Ferreira LCL, Brun IR, Guilherme JP, Monte RL. Estudo dos fatores de risco maternos associados à sepse neonatal precoce em hospital terciário da Amazônia brasileira. Rev Bras Ginecol Obstet. 2007;29(8):387-95.
28. Mohle-Boetani JC, Schuchat A, Plikaytis BD, Smith JD, Broome CV. Comparison of prevention strategies for neonatal group B streptococcal infection. A population-based economic analysis. JAMA. 1993;270(12):1442-8.
29. Akker-van Marle ME, Rijnders ME, Dommelen P, Fekkes M, Wouwe JP, Amelink-Verburg MP, et al. Cost-effectiviness of different treatment strategies with intrapartum antibiotic prophylaxis to prevent early-onset group B streptococcal disease. BJOG. 2005;112(6):820-6.
30. Manning SD, Foxman B, Pierson CL, Tallman P, Baker CJ, Pearlman MD. Correlates of antibiotic-resistant group B streptococcus isolated from pregnant women. Obstet Gynecol. 2003;101(1):74-9.
31. Grimwood K, Stone PR, Gosling IA, Green R, Darlow BA, Lennon DR, et al. Late antenatal carriage of group B Streptococcus by New Zealand women. Aust N Z J Obstet Gynaecol. 2002;42(2):182-6.
32. Uh Y, Kim HY, Jang IH, Hwang GY, Yoon KJ. Correlation of serotypes and genotypes of macrolide-resistant Streptococcus agalactiae. Yonsei Med J. 2005;46(4):480-3.
33. Darbar AA, Gilbert GL. Phenotypical and genotypical characteristics of invasive group B Streptococcus isolates in Western Sydney 2000-2005. Pathology. 2007;39(6):589-93.
34. Simões JA, Alves VM, Francalanza SE, de Camargo RP, Mathias L, Milanez HM, et al. Phenotypical characteristics of group B streptococcus in parturients. Braz J Infect Dis. 2007;11(2):261-6.
35. Karlowsky JA, Jones ME, Mayfield DC, Thornsberry C, Sahm DF. Ceftriaxone activity against Gram-positive and Gram-negative pathogens isolated in US clinical microbiology laboratories from 1996 to 2000: results from The Surveillance Network (TSN) Database-USA. Int J Antimicrob Agents. 2002;19(5):413-26.
36. Garcia SD, Eliseth MC, Lazzo MJ, Copolillo E, Barata AD, de Torres R, et al. Portación de estreptococo grupo B en mujeres embarazadas. Rev Argent Microbiol. 2003;35(4):183-7.